⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage i chronic lymphocytic leukemia

Every month we try and update this database with for stage i chronic lymphocytic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic LeukemiaNCT00436904
Leukemia
Alemtuzumab
Rituximab
18 Years - Mayo Clinic
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic LeukemiaNCT00769522
Chronic Lymphoc...
Rituximab
Bendamustine
Cyclophosphamid...
Fludarabine
18 Years - German CLL Study Group
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaNCT00275054
Chronic Lymphoc...
Fludarabine
Cyclophosphamid...
Rituximab
18 Years - German CLL Study Group
Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic LeukemiaNCT00436904
Leukemia
Alemtuzumab
Rituximab
18 Years - Mayo Clinic
Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic LeukemiaNCT00276809
Chronic Lymphoc...
alemtuzumab
filgrastim
carmustine
cyclophosphamid...
cytarabine
dexamethasone
etoposide
fludarabine pho...
melphalan
autologous bone...
peripheral bloo...
radiation thera...
18 Years - 60 YearsGerman CLL Study Group
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell TransplantNCT00833534
Leukemia
Lymphoma
rituximab
lenalidomide
18 Years - Fred Hutchinson Cancer Center
Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic LeukemiaNCT00278213
Prolymphocytic ...
alemtuzumab
cyclophosphamid...
fludarabine pho...
mitoxantrone hy...
18 Years - 70 YearsGerman CLL Study Group
Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's LymphomaNCT00278161
Leukemia
Lymphoma
Pegfilgrastim
Rituximab
Cyclophosphamid...
18 Years - 70 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Denileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaNCT00026429
Leukemia
Lymphoma
denileukin dift...
18 Years - National Cancer Institute (NCI)
Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaNCT00612612
B-cell Chronic ...
Leukemia
Prolymphocytic ...
Refractory Chro...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
obatoclax mesyl...
fludarabine pho...
rituximab
laboratory biom...
18 Years - National Cancer Institute (NCI)
Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line TherapyNCT02649387
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
Ibrutinib
Laboratory Biom...
18 Years - Mayo Clinic
Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaNCT00513747
Leukemia
rituximab
fludarabine pho...
18 Years - Alliance for Clinical Trials in Oncology
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell TransplantNCT00833534
Leukemia
Lymphoma
rituximab
lenalidomide
18 Years - Fred Hutchinson Cancer Center
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationNCT00005641
Chronic Myelopr...
Graft Versus Ho...
Leukemia
Multiple Myelom...
Myelodysplastic...
anti-thymocyte ...
busulfan
cyclophosphamid...
cyclosporine
leucovorin calc...
methotrexate
methylprednisol...
allogeneic bone...
in vitro-treate...
radiation thera...
15 Years - 60 YearsH. Lee Moffitt Cancer Center and Research Institute
Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaNCT00003174
Leukemia
bryostatin 1
cladribine
18 Years - Barbara Ann Karmanos Cancer Institute
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00918723
Chronic Lymphoc...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Fludarabine Pho...
Cyclophosphamid...
Rituximab
Vorinostat
18 Years - Fred Hutchinson Cancer Center
Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic LeukemiaNCT01649791
B-cell Chronic ...
Chronic Lymphoc...
Stage 0 Chronic...
Stage I Chronic...
Stage II Chroni...
lenalidomide
laboratory biom...
lymph node biop...
bone marrow asp...
pharmacological...
flow cytometry
18 Years - Roswell Park Cancer Institute
Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaNCT00003829
Leukemia
cyclophosphamid...
fludarabine pho...
18 Years - Alliance for Clinical Trials in Oncology
Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell LymphocytosisNCT02309515
Monoclonal B-Ce...
Stage 0 Chronic...
Stage I Chronic...
Stage I Small L...
Laboratory Biom...
Lenalidomide
Pneumococcal 13...
18 Years - Mayo Clinic
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaNCT00551239
Leukemia
Lymphoma
rituximab
fludarabine pho...
pixantrone dima...
18 Years - 120 YearsCTI BioPharma
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic LeukemiaNCT00602459
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
Cyclophosphamid...
Fludarabine Pho...
Laboratory Biom...
Lenalidomide
Rituximab
18 Years - National Cancer Institute (NCI)
Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic LeukemiaNCT01269385
B-cell Chronic ...
Refractory Chro...
Stage 0 Chronic...
Stage I Chronic...
Stage II Chroni...
alemtuzumab
rituximab
PGG beta-glucan
flow cytometry
laboratory biom...
DNA analysis
fluorescence in...
polymerase chai...
polymorphism an...
mutation analys...
18 Years - Mayo Clinic
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic LeukemiaNCT00769522
Chronic Lymphoc...
Rituximab
Bendamustine
Cyclophosphamid...
Fludarabine
18 Years - German CLL Study Group
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic CancerNCT00031980
Anemia
Leukemia
Neutropenia
Thrombocytopeni...
cyclosporine
18 Years - Alliance for Clinical Trials in Oncology
Denileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaNCT00026429
Leukemia
Lymphoma
denileukin dift...
18 Years - National Cancer Institute (NCI)
Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic LeukemiaNCT00003808
Leukemia
theophylline
18 Years - 120 YearsEastern Cooperative Oncology Group
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00918723
Chronic Lymphoc...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Fludarabine Pho...
Cyclophosphamid...
Rituximab
Vorinostat
18 Years - Fred Hutchinson Cancer Center
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaNCT00541034
Leukemia
Lymphoma
rituximab
cyclophosphamid...
pentostatin
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic LeukemiaNCT01361711
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
alemtuzumab
ofatumumab
biopsy
18 Years - Northwestern University
Fludarabine in Treating Patients With Chronic Lymphocytic LeukemiaNCT00049075
Leukemia
fludarabine pho...
16 Years - 120 YearsCanadian Cancer Trials Group
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaNCT01886872
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
Bendamustine Hy...
Ibrutinib
Laboratory Biom...
Quality-of-Life...
Rituximab
65 Years - National Cancer Institute (NCI)
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic CancerNCT00031980
Anemia
Leukemia
Neutropenia
Thrombocytopeni...
cyclosporine
18 Years - Alliance for Clinical Trials in Oncology
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based TherapyNCT01145469
Leukemia
DNA analysis
gene expression...
polymorphism an...
laboratory biom...
medical chart r...
18 Years - 120 YearsEastern Cooperative Oncology Group
Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT01024010
Chronic Lymphoc...
Stage 0 Chronic...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Cyclophosphamid...
Laboratory Biom...
Ofatumumab
Pentostatin
18 Years - Mayo Clinic
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or LeukemiaNCT00004084
Leukemia
Lymphoma
indium In 111 L...
yttrium Y 90 ep...
18 Years - Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)NCT00309881
Chronic Lymphoc...
rituximab
cyclophosphamid...
doxorubicin hyd...
prednisone
vincristine sul...
18 Years - German CLL Study Group
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic LeukemiaNCT00003764
Leukemia
cyclophosphamid...
fludarabine pho...
18 Years - 120 YearsEastern Cooperative Oncology Group
Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic LeukemiaNCT00436904
Leukemia
Alemtuzumab
Rituximab
18 Years - Mayo Clinic
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerNCT00004061
Leukemia
Lymphoma
Oral Complicati...
filgrastim
palifermin
cyclophosphamid...
etoposide
ifosfamide
peripheral bloo...
quality-of-life...
radiation thera...
18 Years - 65 YearsNational Cancer Institute (NCI)
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerNCT00004061
Leukemia
Lymphoma
Oral Complicati...
filgrastim
palifermin
cyclophosphamid...
etoposide
ifosfamide
peripheral bloo...
quality-of-life...
radiation thera...
18 Years - 65 YearsNational Cancer Institute (NCI)
Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaNCT00026351
Leukemia
Lymphoma
rituximab
pentostatin
18 Years - National Cancer Institute (NCI)
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaNCT00262782
Chronic Lymphoc...
Fludarabine
18 Years - 75 YearsGerman CLL Study Group
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7NCT00812669
Leukemia
pegfilgrastim
rituximab
cyclophosphamid...
fludarabine pho...
cytogenetic ana...
fluorescence in...
gene expression...
mutation analys...
protein express...
flow cytometry
laboratory biom...
0 Years - 64 YearsCancer Trials Ireland
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic LeukemiaNCT00281892
Chronic Lymphoc...
Anemia
Fludarabine plu...
Fludarabine mon...
- German CLL Study Group
Flavopiridol in Treating Patients With Chronic Lymphocytic LeukemiaNCT00003620
B-cell Chronic ...
Refractory Chro...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
alvocidib
laboratory biom...
18 Years - National Cancer Institute (NCI)
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic LeukemiaNCT00769522
Chronic Lymphoc...
Rituximab
Bendamustine
Cyclophosphamid...
Fludarabine
18 Years - German CLL Study Group
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)NCT00309881
Chronic Lymphoc...
rituximab
cyclophosphamid...
doxorubicin hyd...
prednisone
vincristine sul...
18 Years - German CLL Study Group
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT01027000
Leukemia
Lymphoma
rituximab
busulfan
cyclophosphamid...
fludarabine pho...
methotrexate
sirolimus
tacrolimus
allogeneic stem...
18 Years - 69 YearsAlliance for Clinical Trials in Oncology
Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT01076556
Chronic Lymphoc...
Prolymphocytic ...
Recurrent Small...
Refractory Chro...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Alvocidib Hydro...
Cyclophosphamid...
Diagnostic Labo...
Pharmacological...
Rituximab
18 Years - National Cancer Institute (NCI)
Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaNCT00006390
Leukemia
alemtuzumab
filgrastim
cyclophosphamid...
peripheral bloo...
radiation thera...
18 Years - 65 YearsEastern Cooperative Oncology Group
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaNCT00551239
Leukemia
Lymphoma
rituximab
fludarabine pho...
pixantrone dima...
18 Years - 120 YearsCTI BioPharma
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic LymphomaNCT00049413
Leukemia
Lymphoma
rituximab
cyclophosphamid...
pentostatin
18 Years - Hoag Memorial Hospital Presbyterian
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic LeukemiaNCT00275015
Chronic Lymphoc...
filgrastim
carmustine
cyclophosphamid...
cytarabine
dexamethasone
etoposide
fludarabine pho...
melphalan
bone marrow abl...
peripheral bloo...
radiation thera...
18 Years - 60 YearsGerman CLL Study Group
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete RemissionNCT00458523
Leukemia
alemtuzumab
fluorescence in...
mutation analys...
flow cytometry
18 Years - National Cancer Institute (NCI)
A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and MelphalanNCT00577278
Graft Versus Ho...
Leukemia
Lymphoma
rituximab
fludarabine pho...
melphalan
sirolimus
tacrolimus
allogeneic hema...
indium In 111 i...
yttrium Y 90 ib...
laboratory biom...
18 Years - 69 YearsCity of Hope Medical Center
Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLLNCT00072007
Leukemia
filgrastim
rituximab
CHOP regimen
cladribine
cyclophosphamid...
doxorubicin hyd...
prednisone
vincristine sul...
18 Years - 65 YearsSwiss Group for Clinical Cancer Research
Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaNCT00098670
B-cell Chronic ...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
alemtuzumab
rituximab
fludarabine pho...
18 Years - National Cancer Institute (NCI)
Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaNCT00006390
Leukemia
alemtuzumab
filgrastim
cyclophosphamid...
peripheral bloo...
radiation thera...
18 Years - 65 YearsEastern Cooperative Oncology Group
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell LymphomasNCT02213913
Adult Grade III...
B-cell Chronic ...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Progressive Hai...
Small Intestine...
Splenic Margina...
Stage 0 Chronic...
Stage I Adult D...
Stage I Adult D...
Stage I Adult D...
Stage I Adult H...
Stage I Adult I...
Stage I Chronic...
Stage I Grade 1...
Stage I Grade 2...
Stage I Grade 3...
Stage I Mantle ...
Stage I Margina...
Stage I Small L...
Stage II Adult ...
Stage II Chroni...
Stage II Small ...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Chron...
Stage III Grade...
Stage III Grade...
Stage III Grade...
Stage III Mantl...
Stage III Margi...
Stage III Small...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Chroni...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Mantle...
Stage IV Margin...
Stage IV Small ...
Testicular Lymp...
Untreated Hairy...
Waldenström Mac...
lenalidomide
etoposide
prednisone
vincristine sul...
doxorubicin hyd...
cyclophosphamid...
rituximab
quality-of-life...
laboratory biom...
18 Years - University of Chicago
Dasatinib in Treating Patients With Chronic Lymphocytic LeukemiaNCT01441882
Refractory Chro...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
Dasatinib
Laboratory Biom...
Pharmacological...
18 Years - OHSU Knight Cancer Institute
Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic LeukemiaNCT00004218
Leukemia
chlorambucil
cyclophosphamid...
doxorubicin hyd...
fludarabine pho...
prednisolone
vincristine sul...
- National Cancer Institute (NCI)
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00602836
Leukemia
Lymphoma
Rituximab
Cyclophosphamid...
Lenalidomide
Pentostatin
18 Years - 120 YearsMayo Clinic
Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic LeukemiaNCT00265915
Leukemia
rituximab
sargramostim
15 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT01351896
Ann Arbor Stage...
Ann Arbor Stage...
Chronic Lymphoc...
Chronic Lymphoc...
Small Lymphocyt...
Small Lymphocyt...
Stage 0 Chronic...
Stage I Chronic...
Stage II Chroni...
Laboratory Biom...
Lenalidomide
Pharmacological...
Pneumococcal Po...
18 Years - 79 YearsNational Cancer Institute (NCI)
Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT01351896
Ann Arbor Stage...
Ann Arbor Stage...
Chronic Lymphoc...
Chronic Lymphoc...
Small Lymphocyt...
Small Lymphocyt...
Stage 0 Chronic...
Stage I Chronic...
Stage II Chroni...
Laboratory Biom...
Lenalidomide
Pharmacological...
Pneumococcal Po...
18 Years - 79 YearsNational Cancer Institute (NCI)
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic CancerNCT00004132
Drug/Agent Toxi...
Leukemia
Lymphoma
Multiple Myelom...
Oral Complicati...
Radiation Toxic...
filgrastim
palifermin
cyclophosphamid...
etoposide
ifosfamide
quality-of-life...
radiation thera...
12 Years - 65 YearsNational Cancer Institute (NCI)
Denileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaNCT00026429
Leukemia
Lymphoma
denileukin dift...
18 Years - National Cancer Institute (NCI)
Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell TransplantNCT00920842
Cardiovascular ...
Leukemia
Long-term Effec...
Metabolic Syndr...
9 Years - 21 YearsFred Hutchinson Cancer Center
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaNCT00262743
Leukemia
Polyphenon E
18 Years - Mayo Clinic
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaNCT00551239
Leukemia
Lymphoma
rituximab
fludarabine pho...
pixantrone dima...
18 Years - 120 YearsCTI BioPharma
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00602836
Leukemia
Lymphoma
Rituximab
Cyclophosphamid...
Lenalidomide
Pentostatin
18 Years - 120 YearsMayo Clinic
Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaNCT00004857
Leukemia
alemtuzumab
fludarabine pho...
18 Years - Alliance for Clinical Trials in Oncology
Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell LymphocytosisNCT02309515
Monoclonal B-Ce...
Stage 0 Chronic...
Stage I Chronic...
Stage I Small L...
Laboratory Biom...
Lenalidomide
Pneumococcal 13...
18 Years - Mayo Clinic
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaNCT00262743
Leukemia
Polyphenon E
18 Years - Mayo Clinic
Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic LeukemiaNCT00005579
Leukemia
Lymphoma
dolastatin 10
18 Years - National Cancer Institute (NCI)
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic LeukemiaNCT00602459
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
Cyclophosphamid...
Fludarabine Pho...
Laboratory Biom...
Lenalidomide
Rituximab
18 Years - National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Chronic Lymphocytic LeukemiaNCT00003620
B-cell Chronic ...
Refractory Chro...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage IV Chroni...
alvocidib
laboratory biom...
18 Years - National Cancer Institute (NCI)
Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic LeukemiaNCT00563290
Recurrent Skin ...
Squamous Cell C...
Stage 0 Chronic...
Stage I Chronic...
dasatinib
laboratory biom...
18 Years - National Cancer Institute (NCI)
Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After ChemotherapyNCT00004040
Leukemia
Multiple Myelom...
recombinant int...
rituximab
- Hoag Memorial Hospital Presbyterian
Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First RemissionNCT00476047
Lymphoid Leukem...
Stage I Chronic...
Stage II Chroni...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Tositumomab and...
18 Years - Fred Hutchinson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: